- Home
- ULCC vs IMTX Comparison
ULCC vs IMTX Comparison
Compare ULCC & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ULCC | IMTX |
|---|---|---|
| Founded | 1994 | N/A |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2017 | 2020 |
Fundamental Metrics
Financial Performance| Metric | ULCC | IMTX |
|---|---|---|
| Price | $4.84 | $7.10 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 12 | 9 |
| Target Price | $6.33 | ★ $17.26 |
| AVG Volume (30 Days) | ★ 2.4M | 828.5K |
| Earning Date | 11-04-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,724,000,000.00 | N/A |
| Revenue This Year | $31.34 | N/A |
| Revenue Next Year | $10.62 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.02 | $6.73 |
| 52 Week High | $8.41 | $12.41 |
Technical Indicators
Market Signals| Indicator | ULCC | IMTX |
|---|---|---|
| Relative Strength Index (RSI) | 28.18 | 31.60 |
| Support Level | $4.74 | N/A |
| Resistance Level | $5.46 | $10.08 |
| Average True Range (ATR) | 0.28 | 0.41 |
| MACD | -0.12 | -0.08 |
| Stochastic Oscillator | 4.83 | 14.40 |
Price Performance
Historical ComparisonAbout ULCC Frontier Group Holdings Inc.
Frontier Group Holdings Inc is an ultra-low-cost carrier whose business is focused on Low Fares Done Right. The company owns a fleet of 120 Airbus single-aisle aircraft, consisting of 13 A320ceos, 82 A320neos, 21 A321ceos, and 4 A321neos. The use of these aircraft, their seating configuration, weight-saving tactics, and baggage process have all contributed to the ability to continue to be the fuel-efficient of all the U.S. The Company is managed as a single business unit that provides air transportation for passengers. The majority of revenue is from Domestic flight follow by International.
About IMTX Immatics N.V.
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.